Personalized cardiac rehabilitation after an acute coronary event, focused on women and frail patients
Official title: Patient-centered Cardiac rehaBilitation pRogramE in Post Acute Coronary Syndrome:Identification of Key Barriers and Evaluation of Personalized Intervention (BREAK-trial)
Run by Institut d'Investigació Biomèdica de Bellvitge · NCT07038265 · Data updated 2026-11-12
This project will test a personalized, patient-centered cardiac rehabilitation program to see if it helps people—especially women and frail patients—recover better after an acute coronary syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 202 (estimated) |
| Sponsor | Institut d'Investigació Biomèdica de Bellvitge Academic / other |
| Locations | 1 site (L'Hospitalet de Llobregat, Barcelona) |
| Status | Recruiting |
| Started | May 26, 2025 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | June 26, 2025 |
| Trial ID | NCT07038265 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) discharged within 30 days after an acute coronary syndrome who can communicate and provide informed consent, particularly women and those identified as frail or with sarcopenia, are ideal candidates.
✕Probably not a fit
Patients who are institutionalized, have life expectancy under one year, have severe cognitive or psychiatric impairment without caregiver support, have planned major cardiac surgery or transplant, or cannot consent are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The BREAK-CR program is a single-center, open-label randomized controlled trial with blinded end-point adjudication that compares an integrated, multidisciplinary, patient-centered cardiac rehabilitation program to usual care for patients recently hospitalized with an acute coronary syndrome. The study begins with a qualitative phase to identify barriers and facilitators to program participation among women and frail patients and then implements a tailored intervention based on those findings. Key outcomes include feasibility, adherence, functional capacity, safety, patient satisfaction, and quality of life. Participants are randomized to the personalized program or standard cardiac rehabilitation and followed through program completion to compare incorporation and clinical outcomes.
Why it matters
Potential benefit: If successful, the program could increase enrollment and adherence to cardiac rehabilitation among women and frail survivors, improving functional recovery, satisfaction, and quality of life.
How similar studies have gone: Prior smaller and targeted rehabilitation programs have shown that tailored, gender-sensitive approaches can boost participation and outcomes, but comprehensive interventions explicitly designed for women and frail ACS survivors remain relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient aged ≥ 18 years 2. Patients discharged within the last 30 days after an admission for ACS or in the discharge planning process for an admission for ACS. 3. The patient is able to fully communicate with the research team and comply with all study procedures. 4. The patient voluntarily signs and dates the informed consent form approved by the ethics committee Exclusion Criteria: 1. Age \<18 years 2. Participation in another clinical trial 3. Moderate or severe cognitive impairment in the absence of a competent caregiver 4. Absence of social support 5. Institutionalized patient 6. Life expectancy \<1 year 7. Candidates for end-of-life care 8. Severe psychiatric illness 9. Planned cardiac surgery including transplant or circulatory support implant 10. Death before hospital discharge in patients included in the hospital discharge planning phase 11. Carrier of heart transplant. 12. Patient unable or refusing to give written informed consent to participate 13. Patients who, in the opinion of the investigator, are unsuitable candidates for the study
Where it's running
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Cristina Enjuanes, MD, PhD — Institut d'Investigació Biomèdica de Bellvitge
- Study coordinator: Cristina Enjuanes Grau, MD, PhD
- Email: cenjuanes@bellvitgehospital.cat
- Phone: +34 93 260 7078
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to reduce anxiety and improve vital signs and satisfaction for women having gynecologic cancer surgery
This study will try a short virtual reality relaxation session before open gynecologic cancer surgery to reduce anxiety and help stabilize heart rate, blood pressure, and patient satisfaction.
-
A large-scale digital health study using Apple devices
This study is trying to see how data from Apple devices can help us understand and manage different health issues like mental health, sleep, and exercise for a wide range of people.
-
Postprandial drop and frailty in older adults having planned noncardiac surgery
This study tests whether a drop in blood pressure after meals and frailty predict low blood pressure after anesthesia starts in adults 65 and older undergoing planned noncardiac surgery.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Frailty Training for Emergency Nurses in Morocco
This trial tests whether a four-module training program helps Moroccan emergency nurses recognize and care for frail older adults in the ER.
-
Physical Function and Fall Risk in Older Adults in Lalín's Frailty Prevention Program
This study will look at how physical function and fall risk change in people 70 and older who participate in a routine frailty and falls prevention program, by comparing assessments before and after the 8–12 week program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.